Mindfulness for Women with Coronary Artery Disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study focuses on women with diagnosed coronary artery disease and elevated anxiety. Participants will undergo a mindfulness-based intervention program to see if it can lessen stress and improve emotional well-being. Eligibility includes adults 18-50, ongoing CAD for at least one month, baseline anxiety, and active social support, with exclusions for language/hearing barriers, menopause, and psychiatric disorders. The study is conducted at Kayseri City Hospital in Turkey under the lead sponsor TC Erciyes University. Outcomes will inform whether mindfulness strategies can be effectively tailored for female CAD patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed with coronary artery disease (CAD) for at least 1 month.
* Score of 14 or higher on the Short Form of the State-Trait Anxiety Inventory (STAI-SF) at baseline.
* At least primary school education.
* Age between 18 and 50 years.
* Sexually active.
* Having an active social network.

Exclusion Criteria:

* Individuals with hearing or language impairments that would hinder communication.
* Women who have entered menopause.
* Women with psychiatric disorders.

Discontinuation Criteria:

* Participants who choose to withdraw from the study.
* Participants who miss two intervention sessions.
* Participants with incomplete data on study forms.

Where it's running

• Kayseri Şehir Hastanesi
  Kayseri, Türki̇ye, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Hatice Penekli, Master
• Email: peneklihatice@gmail.com
• Phone: +9

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• TAVI and PCI vs SAVR and CABG in low- and intermediate-risk patients with severe aortic stenosis and CAD

  This observational study compares TAVI plus PCI to SAVR plus CABG for patients who have both severe aortic stenosis and coronary artery disease.

  Recruiting Alexandria University · Alexandria, Alexandira · NCT07926022

• Resveratrol and Estrogen Receptors in Postmenopausal Women with CAD

  This study tests whether taking resveratrol is safe and can change estrogen-related markers in postmenopausal women with coronary artery disease.

  Recruiting InCor Heart Institute · São Paulo, São Paulo · NCT07865377

• Predicting Plaque Growth Using Blood Flow Stress Markers

  This study tests whether combining blood flow patterns in the heart arteries with how blood-flow–sensitive cells respond can help predict which plaques will grow in people with coronary artery disease.

  Recruiting Queen Mary University of London · London · NCT07864051

• Identifying Coronary Plaque Traits with Photon-counting CT and Multimodality Imaging

  This study tests whether advanced imaging can better identify risky artery plaques in people with stable angina.

  Recruiting Queen Mary University of London · London · NCT07864025

• Health for Hungary: Long-term blood and health data collection to study aging and disease onset

  This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.

  Recruiting at 21 sites Center for Molecular Fingerprinting Research Nonprofit LLC · Balatonfüred and 32 other locations · NCT07743021

• Coronary Extension Catheter in PCI for CAD patients

  This study tests whether using a coronary extension catheter during PCI helps adults with coronary artery disease.

  Recruiting BrosMed Medical Co., Ltd · Beijing · NCT07742345

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.